arrow
Return

Dose-Finding Trials Optimizing Phase 2 Data in the Drug Development Process

delete2015-12-01
delete12
PRE
AI
K
Kert Viele *
J
Jason T. Connor
DOI:10.1001/jama.2015.16702delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

J
JAMA-Journal of the American Medical Association
IF:
55
Papers:
4.1W
Citations:
19.4W

Organization

B
berry consultants llc
Scholars:
170
Papers: 152
Citations: 1